Analysis of Rifampicin in Dried Blood Spot of Tuberculosis Patients for Therapeutic Drug Monitoring using High Performance Liquid Chromatography

    Published on:January 2018
    Journal of Young Pharmacists, 2018; 10(1):48-51
    Original Article | doi:10.5530/jyp.2018.10.12

    Yahdiana Harahap1, Fauzan Alkindy1, Ghina Ashiila1, Rahmayanti2

    1Faculty of Pharmacy, Universitas Indonesia, UI Depok Campus, Depok, 16424, INDONESIA.

    2Bekasi General Hospital, Bekasi, INDONESIA.


    Objective: This research aimed to determine rifampicin in dried blood spot of tuberculosis patients using cilostazol as internal standard by high performance liquid chromatography for supporting therapeutic drug monitoring. Method: Analytes were extracted by protein precipitation using methanolacetonitril (4:1). The analytical separation was performed on C-8 column (Waters, Sun fire™ 5 μm; 250 x 4.6 mm) with column temperature of 40°C. The mobile phase used was acetonitrile - methanol - ammnonium acetate buffer pH 4.5 (40:30:30 % v/v) with a flow rate of 0.5 mL/min; and detected at 261 nm. Results: The method had a chromatographic run time of 16 min and linear calibration curve over the range of 1-30 μg/mL with a correlation coefficient (r) of 0.998. The result of the analysis of rifampicin in 18 tuberculosis patients showed that the measured value of rifampicin was in the range of 1.26 to 18.33 μg/ml. Conclusion: Based on the result, the concentration of rifampicin in patients were varied. There were 7 of 18 patients which had concentration in therapeutic range, showing that the treatment is appropriate, while 11 of 18 patients had concentration below the therapeutic range showing that dose adjustment is needed.

    Key words: Rifampicin, HPLC, Tuberculosis, Validation, Dried blood spot.

    Article Download


    SCImago Journal & Country Rank